Myotonic dystrophy (DM) is the most common form of adult onset muscular dystrophy, with an incidence of about 1 in 8,000 adults. The most common form of the disease, DM1, is caused by an expanded CTG repeat in the 3'UTR of the DMPK gene, and CUG repeat RNAs from this gene fold into hairpins that accumulate in nuclear foci, resulting in effective depletion of the alternative splicing factor Muscleblind (MBNL1) and hyperactivation of the splicing factor CUG Binding Protein 1 (CUGBP1). Misregulation of splicing by these factors is central in the disease. Thus, characterization of the spectrum of changes in the transcriptomes of DM patients is central to understanding disease pathogenesis. This project seeks to understand the molecular basis of DM and to identify genes and mRNA isoforms suitable for therapeutic intervention using an approach based on next-generation sequencing of mRNAs. The project has the following specific aims: 1) To generate a comprehensive catalog of genes, exons and mRNA isoforms whose expression is altered in DM, and to assess the variability of these changes between individuals. 2) To characterize gene and mRNA isoform expression changes in mouse models of DM. 3) To associate gene and isoform changes with clinical and pathological features in DM. Achieving these aims will lay the foundation for a deeper understanding of DM and will generate leads for future molecular genetics and screening studies and is likely to identify candidate therapeutic targets.

Public Health Relevance

This research project will comprehensively determine the changes in RNA and protein molecules that occur in the muscles of patients affected by myotonic dystrophy, which is the most common adult onset form of muscular dystrophy, affecting 1 in 8,000 adults. Knowledge of these molecular changes will help to identify which molecules and genes underlie specific symptoms of the disease and will aid in identifying targets for therapy.

Agency
National Institute of Health (NIH)
Institute
National Human Genome Research Institute (NHGRI)
Type
High Impact Research and Research Infrastructure Programs (RC2)
Project #
5RC2HG005624-02
Application #
7943876
Study Section
Special Emphasis Panel (ZHG1-HGR-P (O1))
Program Officer
Wang, Lu
Project Start
2009-09-30
Project End
2012-08-31
Budget Start
2010-09-01
Budget End
2012-08-31
Support Year
2
Fiscal Year
2010
Total Cost
$1,439,889
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Wang, Eric T; Ward, Amanda J; Cherone, Jennifer M et al. (2015) Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins. Genome Res 25:858-71
Wang, Eric T; Cody, Neal A L; Jog, Sonali et al. (2012) Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. Cell 150:710-24
Katz, Yarden; Wang, Eric T; Airoldi, Edoardo M et al. (2010) Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat Methods 7:1009-15